Therefore, exploring the effects of Nrf2 activation on the abnormal C/EBPβ/α‐Syn signaling pathway in a PD mouse model could provide valuable insights into mitigating PD‐like pathology. This evidence concerns the gene CEBPB and Parkinson disease.